Effects of prolonged exposure to cisplatin on cytotoxicity and intracellular drug concentration
- 31 January 1992
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 28 (1) , 82-86
- https://doi.org/10.1016/0959-8049(92)90391-e
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Ondansetron: a new antiemetic for patients receiving cisplatin chemotherapy.Journal of Clinical Oncology, 1990
- Short-termcis-diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cellsCancer Chemotherapy and Pharmacology, 1990
- Two- versus 24-hour infusion of cisplatin: pharmacokinetic considerations.Journal of Clinical Oncology, 1989
- A pharmacokinetic study of high-dose continuous infusion cisplatin in children with solid tumors.Journal of Clinical Oncology, 1989
- Comparative effect of cisplatin, spiroplatin, carboplatin, iproplatin and JM40 in a human myeloid clonogenic assayEuropean Journal of Cancer and Clinical Oncology, 1988
- Pharmacokinetics of free and total platinum species after rapid and prolonged infusions of cisplatinClinical Pharmacology & Therapeutics, 1986
- Pharmacokinetics of free platinum species following rapid, 3-hr and 24-hr infusions of cis-diamminedichloroplatinum (II) and its therapeutic implicationsEuropean Journal of Cancer and Clinical Oncology, 1982
- Pharmacokinetics and protein binding of cis-dichlorodiammine platinum (II) administered as a one hour or as a twenty hour infusionCancer Chemotherapy and Pharmacology, 1980
- Cis-platinum: a new anticancer agent.BMJ, 1979
- Cis-diamminedichloroplatinum (II)Annals of Internal Medicine, 1977